Page 1446 - Williams Hematology ( PDFDrive )

1420 Part X: Malignant Myeloid Diseases Chapter 88: Acute Myelogenous Leukemia 1421

357. Keung YK, Beaty M, Powell BL, et al: Philadelphia chromosome positive myelodys- 389. Avet-Loiseau H, Mechinaud F, Harousseau J-L: Clonal hematologic disorders in
plastic syndrome and acute myeloid leukemia—Retrospective study and review of Down syndrome. J Pediatr Hematol Oncol 17:19, 1995.
literature. Leuk Res 28:579, 2004. 390. Taub J, Huang X, Ge Y, et al: Cystathionine-beta-synthase cDNA transfection alters
358. Saikevych IA, Kerrigan DP, McConnell TS, et al: Multiparameter analysis of acute sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leu-
mixed lineage leukemia: Correlation of a B/myeloid immunophenotype and immu- kemic cells in vitro and in vivo: A model of leukemia in Down syndrome. Cancer Res
noglobulin and T-cell receptor gene rearrangements with the presence of the Phil- 60:6421, 2000.
adelphia chromosome translocation in acute leukemias with myeloid morphology. 391. Lange BJ, Kobrinsky N, Barnard DR, et al: Distinctive demography, biology, and
Leukemia 5:373, 1991. outcome of acute myeloid leukemia and myelodysplastic syndrome in children with
359. Neuman MP, deSolas I, Parkin JL, et al: Monoclonal antibody study of Philadelphia Down syndrome: Children’s Cancer Group Studies 2861 and 2891. Blood 91:608,
chromosome-positive blastic leukemias using the alkaline phosphatase anti-alkaline 1998.
phosphatase (APAAP) technique. Am J Clin Pathol 85:564, 1986. 392. McCoy JP Jr, Overton WR: Immunophenotyping of congenital leukemia. Cytometry
360. Cuneo A, Ferrant A, Michaux JL, et al: Philadelphia chromosome-positive acute mye- 22:85, 1995.
loid leukemia: Cytoimmunologic and cytogenetic features. Haematologica 81:423, 393. Kempski HM, Chessells JM, Reeves BR: Deletions of chromosome 21 restricted to the
1996. leukemia cells of children with Down syndrome and leukemia. Leukemia 11:1973,
361. Bornstein RS, Nesbit M, Kennedy BJ: Chronic myelogenous leukemia presenting in 1997.
blast crisis. Cancer 30:939, 1972. 394. Hama A, Yagasaki H, Takahashi Y, et al: Acute megakaryoblastic leukaemia (AMKL)
362. Peterson LC, Bloomfield CD, Brunning RD: Blast crisis as an initial or terminal man- in children: A comparison of AMKL with and without Down syndrome. Br J Haematol
ifestation of chronic myeloid leukemia. Am J Med 60:209, 1976. 140:552, 2008.
363. Worm AM, Pedersen-Bjergaard J: Chronic myelocytic leukemia presenting in blast 395. Hasle H, Abrahamsson J, Arola M, et al: Myeloid leukemia in children 4 years or
transformation. Scand J Haematol 18:288, 1977. older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of
364. Kantarjian HM, Talpaz M, Chingra K, et al: Significance of the p210 versus p190 relapse are more akin to sporadic AML. Leukemia 22:1428, 2008.
molecular abnormalities in adults with Philadelphia chromosome-positive acute leu- 396. Malinge S, Chlon T, Dore LC, et al: Development of acute megakaryoblastic leukemia
kemia. Blood 78:2411, 1991. in Down syndrome is associated with sequential epigenetic changes. Blood 122:e33,
365. Chen SJ, Flandrin G, Daniel M-T, et al: Philadelphia-positive acute leukemia: Lineage 2013.
promiscuity and inconsistently rearranged breakpoint cluster region. Leukemia 2:261, 397. Ravindranath Y, Abella E, Kruscher JP, et al: Acute myeloid leukemia (AML) in
1988. Down’s syndrome is highly responsive to chemotherapy: Experience on Pediatric
366. Price CM, Rassool F, Shivji MK, et al: Rearrangement of the breakpoint cluster region Oncology Group AML Study 8498. Blood 80:2210, 1992.
and expression of p210 BCR-ABL in a “masked” Philadelphia chromosome-positive 398. Pui C-H, Kane JR, Crist WM: Biology and treatment of infant leukemias. Leukemia
acute myeloid leukemia. Blood 72:1829, 1988. 9:762, 1995.
367. Westbrook CA, Hooberman AL, Spino C, et al: Clinical significance of the BCR-ABL 399. Taga T, Salto AM, Kudo K, et al: Clinical characteristics and outcome of refrac-
fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B tory/relapsed myeloid leukemia in children with Down syndrome. Blood 120:1810,
study. Blood 80:2983, 1992. 2012.
368. Lim LC, Heng KK, Vellupillai M, et al: Molecular and phenotypic spectrum of de novo 400. Lampert F, Harbott J, Ritterbach J: Cytogenetic findings in acute leukaemias of infants.
Philadelphia positive acute leukemia. Int J Mol Med 4:665, 1999. Br J Cancer Suppl 18:S20, 1992.
369. Vandenberghe E, Martiat P, Baens M, et al: Megakaryoblastic leukemia with an N-ras 401. Nagasaka M, Maeda S, Maeda H, et al: Four cases of t(4;11) acute leukemia and its
mutation and late acquisition of a Philadelphia chromosome. Leukemia 5:683, 1991. myelomonocytic nature in infants. Blood 61:1174, 1983.
370. Helenglass G, Testa JR, Schiffer CA: Philadelphia chromosome-positive acute leuke- 402. Hunger SP, Cleary ML: What significance should we attribute to the detection of MLL
mia. Am J Hematol 25:311, 1987. fusion transcripts? Blood 92:709, 1998.
371. Mecucci C, Noens L, Aventin A, et al: Philadelphia-positive acute myelomonocytic 403. Bresters D, Reus AC, Veerman AJ, et al: Congenital leukaemia: The Dutch experience
leukemia with inversion of chromosome 16 and eosinobasophils. Am J Hematol 27:69, and review of the literature. Br J Haematol 7:513, 2002.
1988. 404. Osada S, Horibe K, Oiwa K, et al: A case of infantile acute monocytic leukemia caused
372. Kurzrock R, Shtalrid M, Talpaz M, et al: Expression of c-abl in Philadelphia-positive by vertical transmission of the mother’s leukemic cells. Cancer 65:1146, 1990.
acute myelogenous leukemia. Blood 70:1584, 1987. 405. Lampkin BC, Peipon JJ, Price JK, et al: Spontaneous remission of presumed congenital
373. Smadja N, Krulik M, DeGramont A, et al: Acquisition of Philadelphia chromosome acute nonlymphoblastic leukemia (ANLL) in a karyotypically normal neonate. Am J
concomitant with transformation of a refractory anemia into acute leukemia. Cancer Pediatr Hematol Oncol 7:346, 1985.
55:1477, 1985. 406. Lauria F, Raspadori D, Ventura MA, et al: The presence of lymphoid-associated anti-
374. Primo D, Tabernero MD, Rasillo A, et al: Patterns of BCR/ABL gene rearrangements gens in adult acute myeloid leukemia is devoid of prognostic relevance. Stem Cells
by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemia: Inci- 13:428, 1995.
dence and underlying genetic abnormalities. Leukemia 17:1124, 2003. 407. Carbonell F, Swansbury J, Min T, et al: Cytogenetic findings in acute biphenotypic
375. Lo Coco F, Basso G, di Celle PF, et al: Molecular characterization of Ph + hybrid acute leukaemia. Leukemia 10:1283, 1996.
′
leukemia. Leuk Res 13:1061, 1989. 408. Greaves MF, Chan LC, Furley AJ, et al: Lineage promiscuity in hemopoietic differen-
376. Janssens AM, Offner FC, Van Hove WZ: Bone marrow necrosis. Cancer 88:1769, tiation and leukemia. Blood 67:1, 1986.
2000. 409. Neame PB, Soamboonsrup P, Browman G, et al: Simultaneous or sequential expres-
377. Vermeersch P, Zachee P, Brusselmans C: Acute myeloid leukemia with bone marrow sion of lymphoid and myeloid phenotypes in acute leukemia. Blood 65:142, 1985.
necrosis and Charcot Leyden crystals. Am J Hematol 82:1029, 2007. 410. Scott CS, Vulliamy T, Catovsky D, et al: DNA genotypic conservation during
378. Yumura-Yagi K, Hara J, Talva A, Kawa-Ha K: Phenotypic characteristics of acute phenotypic switch from T-cell acute lymphoblastic leukaemia to acute myeloblastic
megakaryocytic leukemia and transient myelopoiesis. Leuk Lymphoma 13:393, 1994. leukaemia. Leuk Lymphoma 1:21, 1989.
379. Bhatt S, Schreck R, Graham JM, et al: Transient leukemia with trisomy 21. Am J Med 411. Jensen AW, Hokland M, Jorgensen H, et al: Solitary expression of CD 7 among T-cell
Genet 58:310, 1995. antigens in acute myeloid leukemia. Blood 78:1291, 1991.
380. Litz CE, Davies S, Brunning RD, et al: Acute leukemia and the transient myeloprolif- 412. Ferra F, DelVecchio L: Clinical relevance of acute mixed-lineage leukemia. Blood
erative disorder associated with Down syndrome: Morphologic immunophenotypic 79:2799, 1992.
and cytogenetic manifestations. Leukemia 9:1432, 1999. 413. Miwa H, Nakase K, Kita K: Biological characteristics of CD7(+) acute leukemia. Leuk
381. Ito E, Kasai M, Hayashi Y, et al: Expression of erythroid-specific genes in acute Lymphoma 21:239, 1996.
megakaryoblastic leukaemia and transient myeloproliferative disorder in Down syn- 414. Suzuki R, Yamamoto K, Seto M, et al: CD7+ and CD56+ myeloid/natural killer cell
drome. Br J Haematol 90:607, 1995. precursor acute leukemia: A distinct hematolymphoid disease entity. Blood 90:2417,
382. Kurukashi H, Junichi H, Keiko Y, et al: Monoclonal nature of transient abnormal mye- 1997.
lopoiesis in Down’s syndrome. Blood 77:1161, 1991. 415. Scott AA, Head DR, Kropecky KJ, et al: HLA-DR–, CD33+, CD56+, CD16– myeloid/
383. Apollonsky N, Shende A, Ouansafi I, et al: Transient myeloproliferative disorder in natural killer cell acute leukemia. Blood 84:244, 1994.
neonates with and without Down syndrome: A tale of 2 syndromes. J Pediatr Hematol 416. Paietta E, Gallagher RE, Wiernik PH: Myeloid/natural killer cell acute leukemia. Blood
Oncol 30:860, 2008. 84:2824, 1994.
384. Muramatsu H, Kato K, Watanabe N, et al: Risk factors for early death in neonates with 417. Lee PS, Lin CN, Liu C, et al: Acute leukemia with myeloid, B-, and natural killer cell
Down syndrome and transient leukaemia. Br J Haematol 142:610, 2008. differentiation. Arch Pathol Lab Med 127:E93, 2003.
385. Gamis AS, Hilden J: Transient myeloproliferative disorder. J Pediatr Hematol Oncol 418. Handa H, Motohashi S, Isozumi K, et al: CD7+ and CD56+ myeloid/natural killer
241:2, 2002. cell precursor acute leukemia treated with idarubicin and cytosine arabinoside. Acta
386. Gurbuxani S, Vyas P, Crispino JD: Recent insights into the mechanism of myeloid Haematol 108:47, 2002.
leukemogenesis in Down syndrome. Blood 103:399, 2004. 419. Oshimi K: Progress in understanding and managing natural killer-cell malignancies.
387. Zipursky A, Poon A, Doyle J: Leukemia in Down syndrome: A review. Pediatr Hematol Br J Haematol 139:532, 2007.
Oncol 9:139, 1992. 420. Inhorn RC, Aster JC, Roach SA, et al: A syndrome of lymphoblastic lymphoma, eos-
388. Creutzig U, Ritter J, Vormoor J, et al: Myelodysplasia and acute myelogenous leukemia inophilia, and myeloid hyperplasia malignancy associated with t(8;13) (p11;q11):
in Down’s syndrome. Leukemia 10:1677, 1996. Description of a distinctive clinical entity. Blood 85:1881, 1995.

Kaushansky_chapter 88_p1373-1436.indd 1421 9/21/15 11:02 AM